{"sourcedb":"DevicePMAs@therightstef","sourceid":"P030030_S001","text":"Approval for modification of the labeling to reflect a new device trade name.  The device, as modified, will be marketed under the trade name tegress urethral implant and is indicated for transurethral injection in the treatment of adult women diagnosed with stress urinary incontinence (sui) due to intrinsic sphincter deficiency (isd).","project":"consensus_PMA_Age_Indications"}